BRAIN Initiative: Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (R01 Clinical Trial Not Allowed)
Deadline: February 8, 2029
Opportunity Number: RFA-NS-28-010
Agency: National Institutes of Health
Open Date: September 30, 2026
Close Date: February 8, 2029
Status: Posted
CFDA Numbers: 93.242, 93.867, 93.173, 93.286, 93.865, 93.273, 93.279, 93.853, 93.372, 93.213, 93.866
Mechanistic Evaluation of Therapeutic Targets derived from Treatable Traits to Improve CNS Outcomes in People with HIV (R21/R33 Clinical Trial Not Allowed)
Deadline: October 28, 2027
Opportunity Number: RFA-MH-27-125
Agency: National Institutes of Health
Open Date: September 30, 2026
Close Date: October 28, 2027
Status: Posted
CFDA Numbers: 93.853, 93.242, 93.279
FY 2027 Continuation of Solicitation for the Office of Science Financial Assistance Program
Deadline: September 30, 2027
Opportunity Number: DE-FOA-0003665
Agency: Office of Science
Open Date: September 30, 2026
Close Date: September 30, 2027
Status: Posted
CFDA Numbers: 81.049
HEAL Initiative: Whole Joint Health Program (R61/R33 Clinical Trial Required)
Deadline: October 30, 2026
Opportunity Number: PAR-27-045
Agency: National Institutes of Health
Open Date: September 28, 2026
Close Date: October 30, 2026
Status: Posted
CFDA Numbers: 93.473, 93.273, 93.866, 93.846, 93.853, 93.121, 93.213, 93.286
National Parks Business Plan Internship
Deadline: January 4, 2027
Opportunity Number: P26AS00055
Agency: National Park Service
Open Date: September 28, 2026
Close Date: January 4, 2027
Status: Posted
CFDA Numbers: 15.954
NASA Innovative Advanced Concepts (NIAC) Phase I
Deadline: October 28, 2026
Opportunity Number: NNH26ZTR001N-27NIAC-A1
Agency: NASA Headquarters
Open Date: September 28, 2026
Close Date: October 28, 2026
Status: Posted
CFDA Numbers: 43.012
NEI Translational Research Program for Therapeutics (R61/R33 Clinical Trial Not Allowed)
Deadline: November 16, 2029
Opportunity Number: PAR-28-072
Agency: National Institutes of Health
Open Date: September 25, 2026
Close Date: November 16, 2029
Status: Posted
CFDA Numbers: 93.867
Pancreatic Cancer Detection Consortium: Management and Data Coordination Unit (U24 Clinical Trial Not Allowed)
Deadline: May 25, 2027
Opportunity Number: PAR-28-057
Agency: National Institutes of Health
Open Date: September 25, 2026
Close Date: May 25, 2027
Status: Posted
CFDA Numbers: 93.393
Pancreatic Cancer Detection Consortium: Research Units (U01 Clinical Trial Optional)
Deadline: November 5, 2029
Opportunity Number: PAR-28-056
Agency: National Institutes of Health
Open Date: September 25, 2026
Close Date: November 5, 2029
Status: Posted
CFDA Numbers: 93.393
Deployed Warfighter Protection FY27
Deadline: March 17, 2027
Opportunity Number: AFPMB-BAA-27-01
Agency: ACC-APG-Detrick
Open Date: September 24, 2026
Close Date: March 17, 2027
Status: Posted
CFDA Numbers: 12.355
BJA FY 2026 Students, Teachers, and Officers Preventing (STOP) School Violence Program
Deadline: October 30, 2026
Opportunity Number: O-BJA-2026-172709
Agency: Bureau of Justice Assistance
Open Date: September 21, 2026
Close Date: October 30, 2026
Status: Posted
CFDA Numbers: 16.839
OJJDP FY 2026 Multistate Mentoring Programs
Deadline: October 29, 2026
Opportunity Number: O-OJJDP-2026-172745
Agency: Office of Juvenile Justice Delinquency Prevention
Open Date: September 21, 2026
Close Date: October 29, 2026
Status: Posted
CFDA Numbers: 16.726
Advancing Global Health
Deadline: February 14, 2027
Opportunity Number: DFOP0017890
Agency: Bureau of Global Health Security and Diplomacy
Open Date: September 21, 2026
Close Date: February 14, 2027
Status: Posted
CFDA Numbers: 19.029
Impact Aid Discretionary Construction Grant Program - 84.041C
Deadline: November 10, 2026
Opportunity Number: DOL-OESE-34832
Agency: Office of Elementary and Secondary Education
Open Date: September 8, 2026
Close Date: November 10, 2026
Status: Posted
CFDA Numbers: 84.041
Accelerating Scale-up and Pre-piloting of Emerging Chemical Technologies (ASPECT)
Deadline: December 1, 2026
Opportunity Number: DE-FOA-0003647
Agency: Golden Field Office
Open Date: September 4, 2026
Close Date: December 1, 2026
Status: Posted
CFDA Numbers: 81.087
Request for Information - Gauging Investor Interest in the Development and Commercialization of Subsurface Energy Technologies
Deadline: November 5, 2026
Opportunity Number: DE-FOA-0003671
Agency: National Energy Technology Laboratory
Open Date: September 3, 2026
Close Date: November 5, 2026
Status: Posted
CFDA Numbers: 81.089
DoW Breast Cancer, Breakthrough Award Levels 1 and 2
Deadline: November 18, 2026
Opportunity Number: HT942526BCRPBTA122
Agency: Defense Health Agency Contracting Activity - DHACA
Open Date: September 3, 2026
Close Date: November 18, 2026
Status: Posted
CFDA Numbers: 12.420
DoW Breast Cancer, Clinical Research Extension Award
Deadline: November 18, 2026
Opportunity Number: HT942526BCRPCREA2
Agency: Defense Health Agency Contracting Activity - DHACA
Open Date: September 3, 2026
Close Date: November 18, 2026
Status: Posted
CFDA Numbers: 12.420
NIH Brain Development Cohorts (NBDC) and Population Assessment of Tobacco and Health (PATH) Study Biospecimen Access (X01 Clinical Trial Not Allowed)
Deadline: April 17, 2029
Opportunity Number: PAR-27-051
Agency: National Institutes of Health
Open Date: September 1, 2026
Close Date: April 17, 2029
Status: Posted
CFDA Numbers: 93.853, 93.279, 93.121, 93.242, 93.273, 93.399
Grants for Early Medical/Surgical Specialists' Transition to Aging Research (GEMSSTAR) (R03 Clinical Trial Optional)
Deadline: July 16, 2028
Opportunity Number: PAR-27-096
Agency: National Institutes of Health
Open Date: September 1, 2026
Close Date: July 16, 2028
Status: Posted
CFDA Numbers: 93.361, 93.121, 93.307, 93.866
Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76 Clinical Trial Not Allowed)
Deadline: June 12, 2028
Opportunity Number: PAR-27-112
Agency: National Institutes of Health
Open Date: September 1, 2026
Close Date: June 12, 2028
Status: Posted
CFDA Numbers: 93.866
Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required)
Deadline: November 10, 2026
Opportunity Number: RFA-AI-27-005
Agency: National Institutes of Health
Open Date: September 1, 2026
Close Date: November 10, 2026
Status: Posted
CFDA Numbers: 93.855
Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required)
Deadline: November 10, 2026
Opportunity Number: RFA-AI-27-002
Agency: National Institutes of Health
Open Date: September 1, 2026
Close Date: November 10, 2026
Status: Posted
CFDA Numbers: 93.855
Development of Candidate Medical Countermeasures (MCMs) and Technologies Against Radiological/Nuclear or Chemical Threats (U01 Clinical Trial Not Allowed)
Deadline: October 9, 2028
Opportunity Number: RFA-AI-27-014
Agency: National Institutes of Health
Open Date: September 1, 2026
Close Date: October 9, 2028
Status: Posted
CFDA Numbers: 93.839, 93.837, 93.853, 93.840, 93.846, 93.867, 93.855, 93.233, 93.279, 93.838
Silvio O. Conte Centers for Basic Neuroscience or Translational Mental Health Research (P50 Clinical Trial Optional)
Deadline: May 25, 2028
Opportunity Number: PAR-27-127
Agency: National Institutes of Health
Open Date: September 1, 2026
Close Date: May 25, 2028
Status: Posted
CFDA Numbers: 93.242